Global and North America Recombinant Protein Drugs Market Status and Future Forecast 2013-2023

September 2018 | 105 pages | ID: G1A99219871EN
99Strategy

Abstracts

Summary

Key Content of Chapters (Including and can be customized)

Part 1: Market Overview, Development, and Segment by Type, Application & Region
Part 2: Global Market by company, Type, Application & Region
Part 3: North America Market by company, Type, Application & Region
Part 4-6: Key Regions of North America Market by Type, Application
Part 7: Company information, Sales, Cost, Margin etc.
Part 8: Conclusion

Market Segment as follows:

By Region

• Global (North America, Europe, Asia etc.)
• North America (United States, Canada, Mexico)

Key Companies

• Novo Nordisk
• Amgen
• Sanofi
• Eli Lilly
• Merck Serono
• Ortho Biotech
• Roche
• Kyowa Hakko Kirin
• Pharmingen
• Abcam
• GenSci
• SL PHARM
• Dongbao Pharm
• Ankebio
• NCPC
• Heng Rui

Market by Type

• Recombinant DNA
• Recombinant RNA

Market by Application

• Pharmaceutical Industry
• Others

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 Novo Nordisk
7.2 Amgen
7.3 Sanofi
7.4 Eli Lilly
7.5 Merck Serono
7.6 Ortho Biotech
7.7 Roche
7.8 Kyowa Hakko Kirin
7.9 Pharmingen
7.10 Abcam
7.11 GenSci
7.12 SL PHARM
7.13 Dongbao Pharm
7.14 Ankebio
7.15 NCPC
7.16 Heng Rui

PART 8 CONCLUSION

List Of Tables

LIST OF TABLES

Table Type of Recombinant Protein Drugs
Table Application of Recombinant Protein Drugs
Table Global Recombinant Protein Drugs Market by Region, 2013-2017 (Million USD)
Table Global Recombinant Protein Drugs Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Recombinant Protein Drugs Market by Company, 2013-2017 (Million USD)
Table Global Recombinant Protein Drugs Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Recombinant Protein Drugs Market by Type, 2013-2017 (Million USD)
Table Global Recombinant Protein Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Recombinant Protein Drugs Market by Application, 2013-2017 (Million USD)
Table Global Recombinant Protein Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Recombinant Protein Drugs Market by Region, 2013-2017 (Million USD)
Table North America Recombinant Protein Drugs Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Recombinant Protein Drugs Market by Company, 2013-2017 (Million USD)
Table North America Recombinant Protein Drugs Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Recombinant Protein Drugs Market by Type, 2013-2017 (Million USD)
Table North America Recombinant Protein Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Recombinant Protein Drugs Market by Application, 2013-2017 (Million USD)
Table North America Recombinant Protein Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Recombinant Protein Drugs Market by Type, 2013-2017 (Million USD)
Table United States Recombinant Protein Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Recombinant Protein Drugs Market by Application, 2013-2017 (Million USD)
Table United States Recombinant Protein Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Recombinant Protein Drugs Market by Type, 2013-2017 (Million USD)
Table Canada Recombinant Protein Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Recombinant Protein Drugs Market by Application, 2013-2017 (Million USD)
Table Canada Recombinant Protein Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Recombinant Protein Drugs Market by Type, 2013-2017 (Million USD)
Table Mexico Recombinant Protein Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Recombinant Protein Drugs Market by Application, 2013-2017 (Million USD)
Table Mexico Recombinant Protein Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Novo Nordisk Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Novo Nordisk
Table Amgen Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Amgen
Table Sanofi Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Sanofi
Table Eli Lilly Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Eli Lilly
Table Merck Serono Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Merck Serono
Table Ortho Biotech Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Ortho Biotech
Table Roche Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Roche
Table Kyowa Hakko Kirin Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Kyowa Hakko Kirin
Table Pharmingen Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Pharmingen
Table Abcam Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Abcam
Table GenSci Information
Table Recombinant Protein Drugs Sales, Cost, Margin of GenSci
Table SL PHARM Information
Table Recombinant Protein Drugs Sales, Cost, Margin of SL PHARM
Table Dongbao Pharm Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Dongbao Pharm
Table Ankebio Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Ankebio
Table NCPC Information
Table Recombinant Protein Drugs Sales, Cost, Margin of NCPC
Table Heng Rui Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Heng Rui

List Of Figures

LIST OF FIGURES

Figure Global Recombinant Protein Drugs Market Share by Type in 2018
Figure Global Recombinant Protein Drugs Market Share by Application in 2018
Figure Global Recombinant Protein Drugs Market Share by Region in 2018
Figure North America Recombinant Protein Drugs Market Share by Region in 2018
Figure Global Recombinant Protein Drugs Market Share by Region in 2017 (Million USD)
Figure Global Recombinant Protein Drugs Market Share by Region in 2017 (Volume)
Figure Global Recombinant Protein Drugs Market Share by Company in 2017 (Million USD)
Figure Global Recombinant Protein Drugs Market Share by Company in 2017 (Volume)
Figure Global Recombinant Protein Drugs Market Share by Type in 2017 (Million USD)
Figure Global Recombinant Protein Drugs Market Share by Type in 2017 (Volume)
Figure Global Recombinant Protein Drugs Market Share by Application in 2017 (Million USD)
Figure Global Recombinant Protein Drugs Market Share by Application in 2017 (Volume)
Figure Global Recombinant Protein Drugs Market Forecast, 2018-2023 (Million USD)
Figure Global Recombinant Protein Drugs Market Forecast, 2018-2023 (Volume)
Figure North America Recombinant Protein Drugs Market Share by Region in 2017 (Million USD)
Figure North America Recombinant Protein Drugs Market Share by Region in 2017 (Volume)
Figure North America Recombinant Protein Drugs Market Share by Company in 2017 (Million USD)
Figure North America Recombinant Protein Drugs Market Share by Company in 2017 (Volume)
Figure North America Recombinant Protein Drugs Market Share by Type in 2017 (Million USD)
Figure North America Recombinant Protein Drugs Market Share by Type in 2017 (Volume)
Figure North America Recombinant Protein Drugs Market Share by Application in 2017 (Million USD)
Figure North America Recombinant Protein Drugs Market Share by Application in 2017 (Volume)
Figure North America Recombinant Protein Drugs Market Forecast, 2018-2023 (Million USD)
Figure North America Recombinant Protein Drugs Market Forecast, 2018-2023 (Volume)
Figure United States Recombinant Protein Drugs Market Share by Type in 2017 (Million USD)
Figure United States Recombinant Protein Drugs Market Share by Type in 2017 (Volume)
Figure United States Recombinant Protein Drugs Market Share by Application in 2017 (Million USD)
Figure United States Recombinant Protein Drugs Market Share by Application in 2017 (Volume)
Figure United States Recombinant Protein Drugs Market Forecast, 2018-2023 (Million USD)
Figure United States Recombinant Protein Drugs Market Forecast, 2018-2023 (Volume)
Figure Canada Recombinant Protein Drugs Market Share by Type in 2017 (Million USD)
Figure Canada Recombinant Protein Drugs Market Share by Type in 2017 (Volume)
Figure Canada Recombinant Protein Drugs Market Share by Application in 2017 (Million USD)
Figure Canada Recombinant Protein Drugs Market Share by Application in 2017 (Volume)
Figure Canada Recombinant Protein Drugs Market Forecast, 2018-2023 (Million USD)
Figure Canada Recombinant Protein Drugs Market Forecast, 2018-2023 (Volume)
Figure Mexico Recombinant Protein Drugs Market Share by Type in 2017 (Million USD)
Figure Mexico Recombinant Protein Drugs Market Share by Type in 2017 (Volume)
Figure Mexico Recombinant Protein Drugs Market Share by Application in 2017 (Million USD)
Figure Mexico Recombinant Protein Drugs Market Share by Application in 2017 (Volume)
Figure Mexico Recombinant Protein Drugs Market Forecast, 2018-2023 (Million USD)
Figure Mexico Recombinant Protein Drugs Market Forecast, 2018-2023 (Volume)